Compare XHR & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XHR | AORT |
|---|---|---|
| Founded | 2007 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2014 | 1996 |
| Metric | XHR | AORT |
|---|---|---|
| Price | $18.14 | $21.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $21.10 | ★ $42.15 |
| AVG Volume (30 Days) | ★ 792.5K | 516.9K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ 326.67 | 165.62 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,078,500,000.00 | $298,836,000.00 |
| Revenue This Year | $3.96 | $11.12 |
| Revenue Next Year | $2.71 | $10.77 |
| P/E Ratio | $95.81 | ★ N/A |
| Revenue Growth | 3.80 | ★ 18.01 |
| 52 Week Low | $11.75 | $19.16 |
| 52 Week High | $22.06 | $48.25 |
| Indicator | XHR | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 48.50 | 32.07 |
| Support Level | $14.26 | $19.49 |
| Resistance Level | $19.82 | $25.04 |
| Average True Range (ATR) | 0.41 | 0.92 |
| MACD | 0.07 | -0.09 |
| Stochastic Oscillator | 58.50 | 25.93 |
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other regions. Xenia's revenue is divided between the sale of rooms, food and beverages, and other sources.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.